Laxbene Junior Neutral Zur Anwendung Bei Kindern Zwischen 6 Monaten Und 8 Jahren (Macrogol 4000)

• Laxbene Junior Neutral, an osmotic laxative, is used to manage constipation in the pediatric population.
• Infant constipation (6 months to 1 year): helps soften stools and promote regular bowel movements.
• Toddler constipation (1 to 3 years): reduces stool hardness and eases passage.
• Childhood functional constipation (3 to 8 years): supports natural defecation patterns without stimulant effects.

• Macrogol 4000 is a high‑molecular‑weight polyethylene glycol that is poorly absorbed from the gastrointestinal tract. By osmotically retaining water in the intestinal lumen, it increases stool water content, reduces stool viscosity, and facilitates transit through the colon. The resulting softer, bulkier stool promotes peristalsis and enables spontaneous evacuation without stimulating intestinal smooth‑muscle receptors.

Laxbene Junior Neutral may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Abdominal bloating: feeling of fullness or swelling in the abdomen.
• Flatulence: increased gas production leading to passing of wind.
• Nausea: mild sensation of queasiness.
• Diarrhoea: loose or watery stools, especially with higher doses.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Electrolyte imbalance: abnormal levels of sodium or potassium with prolonged use.
• Persistent abdominal pain: ongoing discomfort not relieved by usual measures.
• Dehydration: excessive fluid loss leading to thirst and reduced urine output.

When using Laxbene Junior Neutral, certain precautions should be observed to ensure safe and effective therapy.

• Dose adjustment: follow the prescriber’s instructions, especially for infants and younger children.
• Hydration: maintain adequate fluid intake to support the laxative effect.
• Electrolyte monitoring: assess electrolyte status during prolonged treatment.
• Renal impairment: use with caution in children with reduced kidney function.
• Known hypersensitivity: avoid if the child has a documented allergy to macrogol or polyethylene glycol.
• Store at ambient temperature below 25 °C: keep in the original container, protect from moisture and direct sunlight.

Macrogol 4000 has a low potential for drug interactions, but certain co‑administered medicines may be affected.

Major Interactions (Avoid)

• Oral medications with narrow therapeutic windows: concurrent use may reduce absorption and alter efficacy.
• Lithium therapy: increased risk of lithium toxicity due to altered fluid balance.

Moderate Interactions (Monitor Closely)

• Diuretics: monitor electrolytes as combined effect may predispose to imbalance.
• Antacids and iron supplements: may have reduced absorption if taken simultaneously; separate dosing by at least 2 hours.
• Antibiotics (e.g., tetracyclines): possible decreased bioavailability; consider timing adjustments.